NO20072934L - Anvendelse av Ranolazon i kombinasjon med minst ett remodelleringsmiddel for a reversere remodellering av venstre ventikkel ved behandlingen av hjertesvikt - Google Patents
Anvendelse av Ranolazon i kombinasjon med minst ett remodelleringsmiddel for a reversere remodellering av venstre ventikkel ved behandlingen av hjertesviktInfo
- Publication number
- NO20072934L NO20072934L NO20072934A NO20072934A NO20072934L NO 20072934 L NO20072934 L NO 20072934L NO 20072934 A NO20072934 A NO 20072934A NO 20072934 A NO20072934 A NO 20072934A NO 20072934 L NO20072934 L NO 20072934L
- Authority
- NO
- Norway
- Prior art keywords
- remodeling
- treatment
- heart failure
- left ventricular
- ranolazon
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Foreliggende oppfinnelse vedrører en fremgangsmåte for å reversere venstre ventrikkelremodellering ved kombinert administrering av terapeutisk effektive mengder av ranolazin og minst ett samtidig remodellerende middel, som kan være en ACEinhibitor, en ARB eller en betablokker. Fremgangsmåten finner anvendelse i behandlingen av hjertesvikt. Denne oppfinnelsen vedrører også farmasøytiske forrnuleringer som er passende for slike kombinerte administreringer.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US62615404P | 2004-11-09 | 2004-11-09 | |
PCT/US2005/040824 WO2006053161A1 (en) | 2004-11-09 | 2005-11-09 | Use ranolazine in combination with at least one remodeling agent for reversing left ventricular remodeling in the treatment of heart failure |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20072934L true NO20072934L (no) | 2007-08-08 |
Family
ID=35892429
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20072934A NO20072934L (no) | 2004-11-09 | 2007-06-08 | Anvendelse av Ranolazon i kombinasjon med minst ett remodelleringsmiddel for a reversere remodellering av venstre ventikkel ved behandlingen av hjertesvikt |
Country Status (15)
Country | Link |
---|---|
US (2) | US20060111361A1 (no) |
EP (1) | EP1809289A1 (no) |
JP (1) | JP2008519770A (no) |
KR (1) | KR20070084063A (no) |
CN (1) | CN101072562A (no) |
AU (1) | AU2005304421A1 (no) |
BR (1) | BRPI0517650A (no) |
CA (1) | CA2586840A1 (no) |
IL (1) | IL183056A0 (no) |
MX (1) | MX2007005367A (no) |
NO (1) | NO20072934L (no) |
RU (1) | RU2007121707A (no) |
SG (1) | SG156681A1 (no) |
WO (1) | WO2006053161A1 (no) |
ZA (1) | ZA200703697B (no) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4546824B2 (ja) * | 2002-05-21 | 2010-09-22 | ギリアード・パロ・アルト・インコーポレイテッド | 糖尿病を処置する方法 |
AU2007293055B2 (en) * | 2006-09-08 | 2013-08-01 | Cardiopolymers, Inc. | Intramyocardial patterning for global cardiac resizing and reshaping |
US20080153840A1 (en) * | 2006-12-21 | 2008-06-26 | Luiz Belardinelli | Reduction of cardiovascular symptoms |
EP2117550A1 (en) * | 2007-02-13 | 2009-11-18 | CV Therapeutics Inc. | Use of ranolazine for the treatment of non-coronary microvascular diseases |
JP2010518169A (ja) * | 2007-02-13 | 2010-05-27 | ギリアード・パロ・アルト・インコーポレイテッド | 心血管疾患の処置のためのラノラジンの使用 |
US20090111826A1 (en) * | 2007-02-13 | 2009-04-30 | Louis Lange | Use of ranolazine for the treatment of cardiovascular diseases |
US20080248112A1 (en) * | 2007-02-13 | 2008-10-09 | Brent Blackburn | Use of ranolazine for the treatment of coronary microvascular diseases |
WO2008116083A1 (en) * | 2007-03-22 | 2008-09-25 | Cv Therapeutics, Inc. | Use of ranolazine for elevated brain-type natriuretic peptide |
EP2146667A2 (en) * | 2007-04-11 | 2010-01-27 | Henry Ford Health System | Cardiac repair, resizing and reshaping using the venous system of the heart |
US20080299195A1 (en) * | 2007-05-31 | 2008-12-04 | Brent Blackburn | Use of ranolazine for elevated brain-type natriuretic peptide |
WO2008154033A2 (en) * | 2007-06-11 | 2008-12-18 | Symphony Medical, Inc. | Cardiac patterning for improving diastolic function |
US20090012103A1 (en) * | 2007-07-05 | 2009-01-08 | Matthew Abelman | Substituted heterocyclic compounds |
US20100292217A1 (en) * | 2009-05-14 | 2010-11-18 | Gilead Palo Alto, Inc. | Ranolazine for the treatment of cns disorders |
JP2011010865A (ja) | 2009-06-30 | 2011-01-20 | Ikaria Holdings Inc | 肺高血圧の臨床的または超音波心臓検査上の証拠を伴う低酸素性呼吸器不全に罹った満期産およびほぼ満期産の新生児を治療する方法 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2091211T3 (es) * | 1989-06-23 | 1996-11-01 | Syntex Inc | Ranolazina y piperazinas relacionadas utilizadas en el tratamiento de tejidos que sufren una lesion fisica o quimica. |
US20030077229A1 (en) * | 1997-10-01 | 2003-04-24 | Dugger Harry A. | Buccal, polar and non-polar spray or capsule containing cardiovascular or renal drugs |
US6323226B1 (en) * | 1999-10-19 | 2001-11-27 | Texas Heart Institute | Treatment of heart disease with cox-2 inhibitors |
MXPA02007639A (es) * | 2000-02-18 | 2004-08-23 | Cv Therapeutics Inc | Inhibidores de la oxidacion parcial de los acidos grasos en el tratamiento de la falla cardiaca congestiva. |
US20020052377A1 (en) * | 2000-07-21 | 2002-05-02 | Wolff Andrew A. | Method for treating angina |
US20030220344A1 (en) * | 2002-04-04 | 2003-11-27 | Luiz Belardinelli | Method of treating arrhythmias |
-
2005
- 2005-11-09 MX MX2007005367A patent/MX2007005367A/es unknown
- 2005-11-09 EP EP05826116A patent/EP1809289A1/en not_active Withdrawn
- 2005-11-09 CN CNA2005800380175A patent/CN101072562A/zh active Pending
- 2005-11-09 JP JP2007540416A patent/JP2008519770A/ja not_active Withdrawn
- 2005-11-09 US US11/271,168 patent/US20060111361A1/en not_active Abandoned
- 2005-11-09 AU AU2005304421A patent/AU2005304421A1/en not_active Abandoned
- 2005-11-09 BR BRPI0517650-6A patent/BRPI0517650A/pt not_active IP Right Cessation
- 2005-11-09 WO PCT/US2005/040824 patent/WO2006053161A1/en active Application Filing
- 2005-11-09 CA CA002586840A patent/CA2586840A1/en not_active Abandoned
- 2005-11-09 SG SG200907097-0A patent/SG156681A1/en unknown
- 2005-11-09 KR KR1020077010435A patent/KR20070084063A/ko not_active Application Discontinuation
- 2005-11-09 RU RU2007121707/14A patent/RU2007121707A/ru not_active Application Discontinuation
-
2007
- 2007-05-08 IL IL183056A patent/IL183056A0/en unknown
- 2007-05-08 ZA ZA200703697A patent/ZA200703697B/xx unknown
- 2007-06-08 NO NO20072934A patent/NO20072934L/no not_active Application Discontinuation
-
2009
- 2009-02-26 US US12/393,952 patent/US20090176772A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
BRPI0517650A (pt) | 2008-10-14 |
CA2586840A1 (en) | 2006-05-18 |
US20060111361A1 (en) | 2006-05-25 |
SG156681A1 (en) | 2009-11-26 |
US20090176772A1 (en) | 2009-07-09 |
IL183056A0 (en) | 2007-10-31 |
AU2005304421A1 (en) | 2006-05-18 |
EP1809289A1 (en) | 2007-07-25 |
ZA200703697B (en) | 2008-09-25 |
JP2008519770A (ja) | 2008-06-12 |
CN101072562A (zh) | 2007-11-14 |
WO2006053161A8 (en) | 2006-09-14 |
MX2007005367A (es) | 2007-06-18 |
RU2007121707A (ru) | 2008-12-20 |
WO2006053161A1 (en) | 2006-05-18 |
KR20070084063A (ko) | 2007-08-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20072934L (no) | Anvendelse av Ranolazon i kombinasjon med minst ett remodelleringsmiddel for a reversere remodellering av venstre ventikkel ved behandlingen av hjertesvikt | |
NO20065847L (no) | Difenylimidazopyrimidiner og -imidazolaminer som inhibitorer av B-sekretase | |
AR048588A1 (es) | Uso de inhibidores de la fosfodiesterasa de tipo iii (pde iii) para la reduccion del tamano del corazon en mamiferos que padecen insuficiencia cardiaca | |
NO20082497L (no) | Diarylureaer for behandling av pulmonal hypertensjon | |
NO20072654L (no) | Cancer behandling | |
NO20064584L (no) | Tetrahydropyridoindolderivater | |
NO20080187L (no) | Aspartylproteaseinhibitorer | |
EA200800006A1 (ru) | Триазолопиридины в качестве ингибиторов 11-бета-гидроксистероиддегидрогеназы типа i | |
NO20075400L (no) | Fremgangsmater, sammensetninger og formuleringer for a forebygge eller lindre ugunstige virkninger i en pasient | |
NO20050795L (no) | Forbindelser, blandinger og fremgangsmater for utnyttelse av samme | |
ECSP11011030A (es) | Método para tratar o prevenir la trombosis usando etexilato de dabigatrán o una sal del mismo con un perfil de seguridad mejorado sobre la terapia con warfarina convencional. | |
ECSP067076A (es) | Derivados de pirimidina urea como inhibidores de la quinasa | |
NO20092569L (no) | Inhibitorer av Akt-aktivitet | |
NO20074509L (no) | Kombinasjon av organiske forbindelser | |
NO20070933L (no) | Indazoler anvendbare i behandling av kardiovaskulaere sykdommer | |
NO20091296L (no) | Fremgangsmate for behandling av slag med trombolytisk middel | |
NO20071446L (no) | Endotelin A reseptor (ETA)-antagonister i kombinasjon med fosfodiesterase 5-inhibitorer (PDE5) og anvendelser derav. | |
NO20072223L (no) | Glykogenfosforylaseinhibitor forbindelser med farmsoytiske preparater av disse | |
NO20070139L (no) | Heterosykliske derivater for behandling av hyperlipidemi og relaterte sykdommer | |
NO20055474L (no) | Mediatorer av revers kolesteroltransport for behandling av hyperkolesterolemi | |
NO20083333L (no) | Fremgangsmater for forbedring av farmakokinetikken til HIV-integraseinhibitorer | |
NO20053455L (no) | Anvendelse av en kombinasjon inneholdende en ikke-nukleosid revers transkriptase inhibitor (NNRTI) med en inhibitor av cytokrom P450 sa som protease inhibitorer | |
AR119158A1 (es) | Tratamientos de angioedema hereditario | |
NO20054216L (no) | Anvendelse av dipyridamol i kombinasjon med acetylsalisylsyre og en angiotensin II antagonist for forhindring av slag | |
WO2004043456A8 (en) | Cholesterol absorption inhibitors for the treatment of demyelination |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |